CoLabs Int’l, which makes skin care products designed to limit unwanted chemical absorption, withdrew its plans for an initial public offering on Thursday. It had filed in March 2023 to raise $6 million by offering 1.3 million shares at a price range of $4 to $5. The company had not updated its prospectus since then.
The Huntington Beach, CA-based company was founded in 2008 and had planned to list on the Nasdaq under the symbol CLLB. Craft Capital Management and R.F. Lafferty & Co. were set to be the joint bookrunners on the deal.
